China Universal Asset Management »

Myriad Genetics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Myriad Genetics (MYGN) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Myriad Genetics

Tip: Access up to 7 years of quarterly data

All positions including Myriad Genetics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Myriad Genetics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $368k 17k 21.32
2023-12-31 $196k 10k 19.14
2023-09-30 $34k 2.1k 16.04
2023-06-30 $25k 1.1k 23.18
2023-03-31 $26k 1.1k 23.23
2022-12-31 $12k 823 14.51
2022-09-30 $14k 755 18.54

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Myriad Genetics

BlackRock
Vanguard Group
Wellington Management Company
Glenview Captal Management
Millennium Management
Earnest Partners
Dimensional Fund Advisors
Bank of America Corporation
Artisan Partners Limited Partnership
Sei Investments
Disciplined Growth Investors
Geode Capital Management
Morgan Stanley
Nuveen Asset Management
Citadel Advisors

View all funds holding Myriad Genetics